1. Costa JL, Schmitt FC

Liquid Biopsy: A New Tool in Oncology. Acta cytologica 63: 448, 2019. [Editorial Material] 

 doi: 10.1159/000501355 PMID: 31266005.

 

2. Costa JL, Sousa S, Justino A, Kay T, Fernandes S, Cirnes L, Schmitt F, Machado JC

Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting. Human mutation 34: 629-35, 2013. [Article] 

 doi: 10.1002/humu.22272 PMID: 23315985.

 

3. Costa JL, Eijk PP, van de Wiel MA, ten Berge D, Schmitt F, Narvaez CJ, Welsh J, Ylstra B

Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. BMC genomics 10: 499, 2009. [Article] 

 doi: 10.1186/1471-2164-10-499 PMID: 19863778.

 

4. Costa JL, Meijer G, Ylstra B, Caldas C

Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Seminars in radiation oncology 18: 98-104, 2008. [Article] 

 doi: 10.1016/j.semradonc.2007.10.005 PMID: 18314064.

 

1. Fernandes MGO, Cruz-Martins N, Souto Moura C, Guimarães S, Pereira Reis J, Justino A, Pina MJ, Magalhães A, Queiroga H, Machado JC, Hespanhol V, Costa JL

Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer. Cancers 13: ., 2021. [Article] 

 doi: 10.3390/cancers13112707 PMID: 34070940.

 

2. Marques JF, Junqueira-Neto S, Pinheiro J, Machado JC, Costa JL

Induction of apoptosis increases sensitivity to detect cancer mutations in plasma. European journal of cancer (Oxford, England : 1990) 127: 130-138, 2020. [Article] 

 doi: 10.1016/j.ejca.2019.12.023 PMID: 32007713.

 

3. Fernandes MGO, Jacob M, Martins N, Moura CS, Guimarães S, Reis JP, Justino A, Pina MJ, Cirnes L, Sousa C, Pinto J, Marques JA, Machado JC, Hespanhol V, Costa JL

Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation. Cancers 11: ., 2019. [Article] 

 doi: 10.3390/cancers11091229 PMID: 31443496.

 

4. Fernandes Marques J, Pereira Reis J, Fernandes G, Hespanhol V, Machado JC, Costa JL

Circulating Tumor DNA: A Step into the Future of Cancer Management. Acta cytologica 63: 456-465, 2019. [Review] 

 doi: 10.1159/000492917 PMID: 30852572.

 

5. Reis J, Fernandes G, Hespanhol V, Machado JC, Costa JL

Liquid biopsy: looking beyond EGFR mutations Medicine 98: ., 2019. [Meeting Abstract] 

.

 

6. Marques J, Neto SJ, Pinheiro J, Machado JC, Costa JL

Induction of apoptosis increases the sensitivity of detection of relevant mutations in circulation Medicine 98: ., 2019. [Meeting Abstract] 

.

 

7. Neto SJ, Marques J, Rad R, Melo SA, Machado JC, Costa JL

Horizontal transmission of mutation-driven drug resistance in cancer Medicine 98: ., 2019. [Meeting Abstract] 

.

 

8. Machado JC, Reis J, Fernandes M, Silva R, Cirnes L, Carneiro F, Costa JL

Tumor-specific neoantigens drive T-cell clonotype convergence European journal of cancer (Oxford, England : 1990) 92: S11-S11, 2018. [Meeting Abstract] 

.

 

9. Machado JC, Reis J, Fernandes M, Silva R, Cirnes L, Chaudhary R, Carneiro F, Costa JL

Determining tumor mutation load using an NGS-based, target gene panel European journal of cancer (Oxford, England : 1990) 92: S4-S5, 2018. [Meeting Abstract] 

.

 

10. Justino A, Dias P, João Pina M, Sousa S, Cirnes L, Berta Sousa A, Carlos Machado J, Costa JL

Comprehensive massive parallel DNA sequencing strategy for the genetic diagnosis of the neuro-cardio-facio-cutaneous syndromes. European journal of human genetics : EJHG 23: 347-53, 2015. [Article] 

 doi: 10.1038/ejhg.2014.97 PMID: 24896146.